Clinical Trials in Atlanta

Showing 11801-11820 of 19,805 trials

Spatial Cognitive Training

NCT03423654

This study is designed to see if doing regular training on a spatial imagery task leads to improvements in the ability to do the trained spatial imagery task and in the ability to get around in everyday activities.

Blind

VA Office of Research and Development6 participantsStarted Mar 2018

Atlanta, Georgia, United States • Decatur, Georgia, United States

COMPLETEDPhase 2< 1 mile

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

NCT02576938

The purpose of this study is to evaluate the safety and effectiveness of Baricitinib in eczema.

Atopic Dermatitis

Eli Lilly and Company124 participantsStarted Feb 2016

Los Angeles, California, United States • Tampa, Florida, United States • Atlanta, Georgia, United States +10 more locations

Spatial Cognitive Training

A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic Dermatitis

Find Trials by Condition in Atlanta

A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque Psoriasis

Cognitive, Behavioral, and Functional Change in Behavioral Variant Frontotemporal Dementia (bvFTD)

A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart

A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis

Hydroxychloroquine Use in Hospitalized Patients With COVID-19: Impact on Progression to Severe or Critical Disease

A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast Cancer

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF

Phase 1b DV281 With an Anti-PD-1 Inhibitor in NSCLC

A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative Colitis

A Safety Study of Galcanezumab in Participants With Migraine, With or Without Aura

Registry to Evaluate INOmax in Newborn Babies With Pulmonary Hypertension

Study to Evaluate Cinacalcet in Children With Chronic Kidney Disease

Different Doses of BI 1467335 Compared to Placebo in Patients With Clinical Evidence of NASH

A Gene Therapy Study for Hemophilia B

Two Doses of Multimeric-001 (M-001) Followed by Influenza Vaccine

Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)